On The Pen GLP-1 News
Duración total:
20 h 45 min
200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study
On The Pen GLP-1 News
31:09
Eli Lilly Earnings Call Recap: Retatrutide News
On The Pen GLP-1 News
59:57
Novo Nordisk Warned us For Years About Synthesized Semaglutide. Now They Want In.
On The Pen GLP-1 News
18:56
Retatrutide Biologic Battle: The Story Gets Bigger
On The Pen GLP-1 News
20:58
GLP-1 Showdown: Inside The High Stakes War over Patients
On The Pen GLP-1 News
27:13
Medicare, New Drugs, and a Surprising GLP-1 Trend, What Patients Need to Know
On The Pen GLP-1 News
31:56
Compound GLP-1 Poll STUNS THE INTERNET!
On The Pen GLP-1 News
15:37
How To Get $50 GLP-1
On The Pen GLP-1 News
44:31
What Comes After Zepbound? The Biggest ADA 2026 Obesity Drug Breakthroughs
On The Pen GLP-1 News
75:18
Retatrutide Just Reached Bariatric Surgery Results
On The Pen GLP-1 News
48:18
Retatrutide Before FDA Approval? Lilly Just Changed the Conversation
On The Pen GLP-1 News
20:32
Eli Lilly Isn’t Telling Us About Their Future Obesity Drugs
On The Pen GLP-1 News
20:55
Retatrutide, Multi Agonist Obesity Drugs, and the PBM Access War
On The Pen GLP-1 News
30:30
Lilly Bets $8B on Weight Loss Future
On The Pen GLP-1 News
23:03
The Next Two Weeks in GLP1 Are Huge, Here's Why
On The Pen GLP-1 News
67:01
He Took Retatrutide 40mg and Proved a Point
On The Pen GLP-1 News
36:33
Eli Lilly Earnings Call Recap: Q1 2026
On The Pen GLP-1 News
25:01
SURVODUTIDE Phase 3 Data: Why Weight Loss Isn't The Whole Story
On The Pen GLP-1 News
18:33
BPI STOPS TIRZEPATIDE Production, Second Major Pharmacy Out!
On The Pen GLP-1 News
40:31
Retatrutide Could Change Everything… But Who Actually Gets It?
On The Pen GLP-1 News
29:31
Ozempic Personality With Dr Spencer Nadolsky
On The Pen GLP-1 News
42:12
Foundayo GLP-1 Pill: FDA Needs More Data
On The Pen GLP-1 News
20:24
GLP-1 Access Is EXPLODING… But Something Else Is Happening
On The Pen GLP-1 News
23:09
Zepbound Dosing: What Your Doctor Didn't Explain
On The Pen GLP-1 News
73:34
Wegovy Price Drop Exposes a Bigger Problem
On The Pen GLP-1 News
18:48
Retatrutide Is Too Good… And That’s The Problem
On The Pen GLP-1 News
29:24
MASSIVE: Compound Tirzepatide and Semaglutide Updates!
On The Pen GLP-1 News
26:38
Cheap Zepbound Incoming for Medicare, But CMS Just Issued a Catch
On The Pen GLP-1 News
20:28
Gray Market GLP-1 Is Booming Branded Access is Broken
On The Pen GLP-1 News
26:23
UBT251 FROM NOVO NORDISK! BETTER THAN RETATRUTIDE?
On The Pen GLP-1 News
27:26
Wegovy vs Zepbound in 2026: New Higher Dose
On The Pen GLP-1 News
20:36
Compound Tirzepatide: Time to Stock Up?
On The Pen GLP-1 News
31:50
Eli Lilly Earnings Call Q4 2025 Recap
On The Pen GLP-1 News
21:35
Once Monthly GLP-1 Injection? Pfizer Drops New Data
On The Pen GLP-1 News
21:39
PCOS and Tirzepatide Clinical Trial. Finally
On The Pen GLP-1 News
19:29
Over The Counter GLP-1 Prediction
On The Pen GLP-1 News
21:02
GLP-1 PLUS Gastric Balloon for added Weight Loss!
On The Pen GLP-1 News
31:48
GLP-1 Access, MariTide Data, and the Oprah Effect on Obesity Care
On The Pen GLP-1 News
27:54
Wegovy Pens Recalled & Wegovy Pill Launch
On The Pen GLP-1 News
26:11
Wegovy Pill Approved: First Ever GLP-1 Pill, As Good as Injections!
On The Pen GLP-1 News
29:14
